This trade activity should not be overlooked: Inovio Pharmaceuticals Inc (INO)

With 0.54 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.1 million shares. The 52-week range on INO shows that it touched its highest point at $14.75 and its lowest point at $1.74 during that stretch. It currently has a 1-year price target of $9.50. Beta for the stock currently stands at 0.92.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of INO was down-trending over the past week, with a drop of -11.61%, but this was down by -2.46% over a month. Three-month performance dropped to -52.06% while six-month performance fell -73.35%. The stock lost -78.05% in the past year, while it has gained 8.20% so far this year. A look at the trailing 12-month EPS for INO yields -4.48 with Next year EPS estimates of -2.92. For the next quarter, that number is -0.84. This implies an EPS growth rate of 30.90% for this year and 30.64% for next year. EPS is expected to grow by 29.92% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 13.49%.

Float and Shares Shorts:

At present, 36.10 million INO shares are outstanding with a float of 35.88 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for INO since 3 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$3.79048 being high and -$4.68587 being low. For INO, this leads to a yearly average estimate of -$4.20833. Based on analyst estimates, the high estimate for the next quarter is -$0.67 and the low estimate is -$0.67. The average estimate for the next quarter is thus -$0.67.